1. Pink Sheet
  2. >>Geography
  3. >>Europe
  4. >>United Kingdom

New UK Clinical Trials Regulation Expected To Apply From January 2026

 
• By Eliza Slawther

Sponsors can expect to see a copy of final guidance on how to comply with the UK’s new clinical trials regulation in August 2025, while the new framework is set to apply from January 2026.

(Shutterstock)

The UK government has approved plans from the Medicines and Healthcare products Regulatory Agency to move forward with its clinical trials framework reform.

The proposed legislation is “currently in the final stages of legal checks and parliamentary processes that need to take place,” and will be laid before parliament in November, Freya Newton,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

ClinicalTrials.gov Or ISRCTN: Getting Transparency Right For UK Trials

 
• By Vibha Sharma

ISRCTN’s systems are being redesigned to facilitate compliance with upcoming requirements in the UK’s clinical trials legislation.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

Managed Access Agreement Fails To Help BioMarin’s Brineura Secure Routine Reimbursement In England

 
• By Francesca Bruce

BioMarin’s ultra-rare disease drug Brineura has breached cost-effectiveness thresholds for highly specialized treatments in England and looks set to be denied routine funding on the National Health Service.

Inclusive By Design: UK Pilots Diversity Plans For Drug & Device Trials

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

More from Diversity & Inclusion

CRO Group Picks Seven US Sites To Reap Big Gains In Trial Diversity

 
• By Vibha Sharma

The Association of Clinical Research Organizations has awarded “seed funding” to seven US-based community clinical trial sites to demonstrate proof-of-concept projects aimed at increasing diversity in clinical trials.

Kennedy Would Issue Trial Diversity Guidance, But Not Necessarily Roll Back All Anti-DEI Actions

 
• By Sarah Karlin-Smith

The US Health and Human Services Secretary nominee’s commitment should be a positive sign for those who want to ensure Americans can access adequate data on drugs in all populations that could use them.

US FDA’s Trump Transition Relatively Smooth, Except For Diversity, Equity Work

 
• By Sarah Karlin-Smith

Several critical FDA drug activities can skirt early Trump administration directives, but trial diversity and health equity work may be hobbled.